id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0800-0001,FDA,FDA-2011-D-0800,Draft Guidance for Industry; Availability: Regulatory Classification of Pharmaceutical Co-Crystals,Notice,Notice of Availability,2011-12-02T05:00:00Z,2011,12,2011-12-02T05:00:00Z,2012-03-02T04:59:59Z,2011-12-02T14:13:26Z,2011-31022,0,0,0900006480f7a304
FDA-2011-D-0800-0002,FDA,FDA-2011-D-0800,Draft Guidance for Industry; Regulatory Classification of Pharmaceutical Co-Crystals,Other,Guidance,2011-12-02T05:00:00Z,2011,12,2011-12-02T05:00:00Z,,2019-08-20T18:43:48Z,,0,0,0900006480f79638